Hemocompatibility of siRNA loaded dextran nanogels

Biomaterials

Volumn 32, Issue 34, 2011, Pages 9120-9127

  Naeye, Broes ^a   Deschout, Hendrik ^a   Röding, Magnus ^b   Rudemo, Mats ^b   Delanghe, Joris ^c   Devreese, Katrien ^c   Demeester, Jo ^a   Braeckmans, Kevin ^a   De Smedt, Stefaan C ^a   Raemdonck, Koen ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Blood; Blood compatibility; Drug Delivery; Gene therapy; Haemocompatibility; Nanoparticle

Indexed keywords

BLOOD CELLS; BLOOD COMPATIBILITY; DELIVERY SYSTEMS; FLUORESCENCE FLUCTUATION SPECTROSCOPY; HAEMOCOMPATIBILITY; HEMOCOMPATIBILITY; HUMAN BLOOD CELLS; HUMAN PLASMAS; IN-VITRO; IN-VIVO; IN-VIVO EXPERIMENTS; INTRAVENOUS INJECTIONS; MINIMAL INTERACTIONS; NANOGELS; PLATELET AGGREGATION; POSITIVELY CHARGED; SINGLE PARTICLE TRACKING;

AGGLOMERATION; BLOOD; DEXTRAN; DRUG DELIVERY; FLOW CYTOMETRY; GENE THERAPY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; PLASMA (HUMAN); PLATELETS;

CELLS;

DEXTRAN; NANOGEL; NANOMATERIAL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; BLOOD COMPATIBILITY; CELL ADHESION; CELL INTERACTION; DRUG DELIVERY SYSTEM; ERYTHROCYTE; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; GENE THERAPY; GRANULOCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MONOCYTE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

BLOOD CELLS; DEXTRANS; FLOW CYTOMETRY; HUMANS; MATERIALS TESTING; PLATELET AGGREGATION; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RNA, SMALL INTERFERING;

EID: 80053126361     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.015     Document Type: Article

References (29)

1. Fire A., Xu S.Q., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
2. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
3. Davidson B.L., McCray P.B. Current prospects for RNA interference-based therapies. Nat Rev Genet 2011, 12:329-340.
4. Morris K.V. RNA-directed transcriptional gene silencing and activation in human cells. Oligonucleotides 2009, 19:299-306.
5. Jackson A.L., Linsley P.S. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 2010, 9:57-67.
6. Pecot C.V., Calin G.A., Coleman R.L., Lopez-Berestein G., Sood A.K. RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 2011, 11:59-67.
7. Raemdonck K., Vandenbroucke R.E., Demeester J., Sanders N.N., De Smedt S.C. Maintaining the silence: reflections on long-term RNAi. Drug Discov Today 2008, 13:917-931.
8. Whitehead K.A., Langer R., Anderson D.G. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009, 8:129-138.
9. Tiemann K., Rossi J.J. RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol Med 2009, 1:142-151.
10. Sarma J.V., Ward P.A. The complement system. Cell Tissue Res 2011, 343:227-235.
11. Oppermann M., Wurzner R. Modern determination of complement activation. Semin Thromb Hemost 2010, 36:611-619.
12. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 2008, 5:487-495.
13. Radomski A., Jurasz P., Alonso-Escolano D., Drews M., Morandi M., Malinski T., et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 2005, 146:882-893.
14. Merkel O., Librizzi D., Pfestroff A., Schurrat T., Buyens K., Sanders N., et al. Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging. J Contr Release 2009, 138:148-159.
15. van de Water F.M., Boerman O.C., Wouterse A.C., Peters J.G.P., Russel F.G.M., Masereeuw R. Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab Dispos 2006, 34:1393-1397.
16. Owens, Peppas N. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006, 307:93-102.
17. Roerdink F., Dijkstra J., Hartman G., Bolscher B., Scherphof G. The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts. Biochim Biophys Acta 1981, 677:79-89.
18. Moghimi S.M., Patel H.M. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity. Adv Drug Deliv Rev 1998, 32:45-60.
19. Jiang J.K., Oberdorster G., Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanoparticle Res 2009, 11:77-89.
20. Braeckmans K., Buyens K., Bouquet W., Vervaet C., Joye P., Vos F.D., et al. Sizing Nanomatter in biological fluids by fluorescence single particle tracking. Nano Lett 2010, 10:4435-4442.
21. Brigger I., Morizet J., Laudani L., Aubert G., Appel M., Velasco V., et al. Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model. J Contr Release: Official Journal Contr Release Soc 2004, 100:29-40.
22. Raemdonck K., Naeye B., Buyens K., Vandenbroucke R.E., Hogset A., Demeester J., et al. Biodegradable dextran nanogels for RNA interference: focusing on endosomal escape and intracellular siRNA delivery. Adv Funct Mater 2009, 19:1406-1415.
23. Naeye B., Raemdonck K., Remaut K., Sproat B., Demeester J., De Smedt S. PEGylation of biodegradable dextran nanogels for siRNA delivery. Eur J Pharm Sci 2010, 40:342-351.
24. White J.G., Krumwiede M.D., Escolar G. EDTA induced changes in platelet structure and function: influence on particle uptake. Platelets 1999, 10:327-337.
25. Buyens K., Lucas B., Raemdonck K., Braeckmans K., Vercammen J., Hendrix J., et al. A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum. J Contr Release 2008, 126:67-76.
26. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 2008, 105:14265-14270.
27. White J.G. Platelets are covercytes, not phagocytes: uptake of bacteria involves channels of the open canalicular system. Platelets 2005, 16:121-131.
28. Werb Z., Cohn Z.A. Plasma-membrane synthesis in macrophage following phagocytosis of polystyrene latex particles. J Biol Chem 1972, 247:2439.
29. Leijh P.C.J., Vandenbarselaar M.T., Vanzwet T.L., Dubbeldemanrempt I., Vanfurth R. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology 1979, 37:453-465.